Back to results
US 2012/0058153 A1Published application
Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
AssigneeSelecta Biosciences, Inc.
InventorsPetr Ilyinskii, Yun Gao, Grayson B. Lipford
Life of this patent
Estimating the term…
Abstract
This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include polypeptides obtained or derived from human influenza A virus hemagglutinin.
Claims28
A dosage form comprising:
- synthetic nanocarriers that are coupled to polypeptides obtained or derived from human influenza A virus hemagglutinin.
(canceled)
(canceled)
12-13. (canceled)
(canceled)
(canceled)
(canceled)
24-27. (canceled)
A method comprising:
- providing synthetic nanocarriers;
- and
- coupling polypeptides that are obtained or derived from human influenza A virus hemagglutinin to the synthetic nanocarriers.
A process for producing a composition, dosage form or vaccine comprising the steps of:
- providing synthetic nanocarriers;
- and
- coupling polypeptides that are obtained or derived from human influenza A virus hemagglutinin to the synthetic nanocarriers.
32-37. (canceled)
Dependencies are inferred from the claim text.